About
Founded in 2016, Jumpcode’s patented technology unlocks the power of next-generation sequencing by improving sensitivity, reducing costs, simplifying workflows and removing bias. Researchers worldwide are using Jumpcode’s CRISPRclean technology in the fields of basic research, infectious disease, oncology and consumer genomics.
Meet the team

Yaron Hakak, PhD
CEO

Keith Brown
Founder & CTO

Stanley Nelson
Acting Chief Scientist

Azeem Siddique, PhD
Director of R&D

Eva Tseng
Marketing
Scientific advisory board

Shawn Levy, PhD

Gary Schroth, PhD

Gene Yeo, PhD

Nik Schork, PhD

Andrew Su, PhD

Kirk Malloy, PhD
Our investors


